Monod Bio Licenses Protein Technologies to SignalChem Biotech
Monod Bio and SignalChem Biotech announced in a press release a licensing agreement for Monod Bio's LuxSit luciferase technology and NovoBodies.
The agreement is not exclusive. SignalChem Biotech may use the technologies in custom luminescent assays and protein fusion services for research customers.
LuxSit is a luciferase designed with AI for use in luminescent biosensors. NovoBodies are compact binding proteins designed for target recognition.
SignalChem Biotech is a wholly owned subsidiary of Sino Biological. The companies did not disclose financial terms.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Enterprise AI Brief, Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Enterprise
Oct 16 Huawei and 14 partners form Global AI CITY alliance Oct 15 CNN Signs Multi Year AI Content Deal With Google Oct 15 Zealand Pharma signs AI obesity drug deal worth up to $1.2 billion Oct 15 OnePlan Earns FedRAMP High Certification for Government Platform Oct 15 CDE Solutions and Bodega AI Partner on Retail Point of Sale PlatformMore from Life Sciences
Oct 16 Specialty1 Partners Invests in AI for Dental Practice Operations Oct 15 Study Tracks 270 Million Clinical AI Queries on OpenEvidence Oct 15 OpenAI Offers US University Labs Free GPT-Rosalind Access Oct 15 UK Medicines Regulator Plans AI Safety Tools by 2030 Oct 15 Reveleer names Jean-Luc Neptune chief medical officerEnterprise AI Brief
Weekly report on AI business applications, enterprise software releases, automation tools, and industry implementations.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
INmune Bio and QCi Apply Quantum Computing to XPro Research
Cellular Intelligence Adds Yann LeCun and Three Scientists to Advisory Board
Benchling Launches Science Foundries for Biotech R&D
CollPlant Announces $3.7 Million Private Placement for LightSolver
ACROBiosystems Launches ACRO AIx and Rapid Antibody Validation Service
Daily AI Brief: the AI news that matters, in your inbox.